Akari Therapeutics shares are trading lower after the company recently announced a ratio change of its American Depository Shares from 1-representing-100 to 1-representing-2000.
Portfolio Pulse from Benzinga Newsdesk
Akari Therapeutics announced a ratio change of its American Depository Shares from 1-representing-100 to 1-representing-2000, causing its shares to trade lower.
August 17, 2023 | 7:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Akari Therapeutics' shares are trading lower due to a ratio change in its American Depository Shares.
The ratio change in Akari Therapeutics' American Depository Shares means that each share now represents fewer underlying shares, effectively increasing the price per share. This has led to a decrease in demand, causing the shares to trade lower.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100